Publications by authors named "Elga Mayo Montero"
Background: The impact of neuraminidase inhibitors (NAIs) on influenza-related pneumonia (IRP) is not established. Our objective was to investigate the association between NAI treatment and IRP incidence and outcomes in patients hospitalised with A(H1N1)pdm09 virus infection.
Methods: A worldwide meta-analysis of individual participant data from 20 634 hospitalised patients with laboratory-confirmed A(H1N1)pdm09 (n = 20 021) or clinically diagnosed (n = 613) 'pandemic influenza'.
Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data.
Lancet Respir Med
May 2014
Article Synopsis
- The study analyzed the effectiveness of neuraminidase inhibitors in reducing mortality among hospitalized patients with the H1N1 virus during the pandemic.
- Data from 29,234 patients across 78 studies was examined to assess the impact of these antiviral treatments.
- Results showed that neuraminidase inhibitors reduced mortality risk, particularly when administered early (within two days of symptom onset), highlighting the importance of prompt treatment.
Background: On May 19, 2009, 21 cases of influenza-like illness were reported among soldiers from an Engineering Military Academy (ACING) in Hoyo de Manzanares, Spain. In the context of an influenza A (H1N1)2009 global alert, it was decided to investigate a possible pandemic influenza outbreak. To describe a possible outbreak of influenza A (H1N1)2009 in a Military Training Centre and to describe the measures adopted for transmission control of this new infection.
View Article and Find Full Text PDFBackground: Influenza vaccination has shown itself to be effective in reducing morbidity and mortality in patients with underlying chronic respiratory diseases. This study sought to: (1) estimate influenza vaccination coverage among asthma and chronic bronchitis sufferers; (2) ascertain which variables were associated with vaccination; and (3) analyse the time-trend in coverage between 1993 and 2001.
Methods: This was a descriptive study covering the 2611 subjects included in the 1993, 1995, 1997 and 2001 Spanish National Health Surveys who reported suffering from asthma or chronic bronchitis.
Unlabelled: The objective of this study is to describe the evolution of anti-influenza vaccination coverage in Spain from 1993 to 2001. We analysed 55,040 questionnaires taken from the Spanish National Health Surveys from the years 1993, 1995, 1997 and 2001. The reply to the question "Did you vaccinate yourself against influenza during the last campaign?" is the dependent variable.
View Article and Find Full Text PDFBackground: Influenza (flu) is a disease involving a high morbidity which takes a high toll on healthcare costs for which there is an effective vaccine available. This study is aimed at evaluating the evolution of the different degrees of influenza vaccine (flu shot) coverage in Spain by Autonomous Communities during the 1993-2001 period.
Methods: A total of 42,123 cases from the National Health Survey (NHS) for the years 1993 (n=21,051) and 2001 (n=21,072) were analysed, all of which corresponded to non-institutionalised Spanish adults over 15 years of age.